OpenAI has acquired Astral, the company behind Python tools uv and Ruff, to integrate them into its Codex platform as it competes with Anthropic's Claude Code.
Researchers have found a metabolite in Burmese pythons that suppresses appetite in mice without some of GLP-1's side effects. And humans make it, too.
OpenAI announced Thursday that it has entered into an agreement to acquire Astral, the company behind popular open source Python development tools such as uv, Ruff, and ty, and integrate the company ...
March 19 (Reuters) - OpenAI said on Thursday it will acquire Python toolmaker Astral, as the ChatGPT owner looks to ...
Scientists have discovered a novel metabolite in pythons that quells appetite without causing gastrointestinal side effects ...
Abstract: This paper presents a scalable solution for zero-sum, one-sided, partially observable stochastic games (Z-POSGs) in the realm of cybersecurity. Existing heuristic search value iteration ...
Abstract: Effective waste sorting policies are essential for promoting sustainable waste management, yet their impact on regional public sentiments and underlying drivers has received limited ...
mcp-agent's vision is that MCP is all you need to build agents, and that simple patterns are more robust than complex architectures for shipping high-quality agents.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results